Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharm-country crawled date : 2021 - 11 - 11 save search
electroCore to Participate at Canaccord Genuity MedTech & Diagnostics Forum
Published: 2021-11-11 (Crawled : 16:00) - biospace.com/
ECOR | $5.98 5.65% 5.35% 4.9K
|
Health Technology
|
| O: 2.71%
H: 0.93%
C: -1.79%
diagnostics diagnostic
Organon Reports Results for the Third Quarter Ended September 30, 2021
Published: 2021-11-11 (Crawled : 16:00) - biospace.com/
MRK | $127.0 0.1% -1.21% 7.1M
|
Health Technology
|
| O: -0.11%
H: 0.41%
C: 0.12%
results
Rafael Pharmaceuticals Announces First Patient Enrolled in APOLLO 613 Phase 1/2 Clinical Trial of CPI-613® (Devimistat) in Patients with Relapsed Clear Cell SarcomaNew Trial Sites Open at Cleveland Clinic Children’s and University of Michigan
Published: 2021-11-11 (Crawled : 15:00) - biospace.com/
RFL 4 | $1.71 0.0% 4.2K
|
Finance
|
| O: 0.29%
H: 5.17%
C: 0.58%
phase 1 cpi-613 children trial enroll
Amicus Therapeutics to Present at the Stifel 2021 Virtual Healthcare Conference
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
FOLD 4 | $10.52 -1.77% -1.81% 1.6M
|
Health Technology
|
| O: 0.09%
H: 3.13%
C: 1.65%
conference
Celldex to Participate in Upcoming Investor Conferences
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
CLDX | $36.975 -2.11% -2.15% 390K
|
Health Technology
|
| O: 0.33%
H: 1.13%
C: -3.18%
conference
Harmony Biosciences To Participate In Two Investor Conferences In November
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
HRMY | $29.205 1.23% 1.22% 370K
|
Health Technology
|
| O: 0.82%
H: 1.63%
C: -1.02%
conference bioscience
Sio Gene Therapies Announces Successful Manufacture of Three GMP Batches of AXO-Lenti-PD Gene Therapy for Parkinson’s Disease
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 2.07%
H: 2.54%
C: 2.03%
disease gene therapies gene therapy therapy parkinson
Nabriva Announces Availability of XENLETA® (lefamulin) in a 10-Count Oral Pack10-count oral pack – or ‘X’ pack allows for improved access and the opportunity to further expand retail availability
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
NBRV | $1.42 1.39% 720K
|
Health Technology
|
| O: -4.56%
H: 0.81%
C: -2.61%
lefamulin
IN8bio to Present Preclinical Data on the Potential for Gamma-Delta T-cell Therapy Combinations with PARP and Checkpoint Inhibitors in Solid Tumors
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
INAB | $1.03 -0.96% -0.97% 150K
|
|
| O: -3.04%
H: 7.24%
C: -1.81%
solid tumors potential therapy t-cell preclinical pre-clinical
Rocket Pharmaceuticals to Host Webcast on Nov. 15 at 8:30 a.m. ET to Present Updated Danon Disease Clinical Data
Published: 2021-11-11 (Crawled : 13:00) - biospace.com/
RCKT 4 | $23.64 -0.13% -0.13% 920K
|
Health Technology
|
| O: -1.44%
H: 1.49%
C: -0.23%
disease danon disease
Nuvation Bio Reports Third Quarter 2021 Financial Results and Provides Business Update
Published: 2021-11-10 (Crawled : 00:00) - biospace.com/
NUVB | $2.66 -0.75% 0.0% 990K
|
|
| O: 1.37%
H: 0.0%
C: 0.0%
financial results results
Trevi Therapeutics Announces Third Quarter 2021 Financial Results and Business Update
Published: 2021-11-10 (Crawled : 00:00) - biospace.com/
TRVI | $2.68 -5.97% -6.34% 120K
|
Health Technology
|
| O: -1.68%
H: 0.0%
C: 0.0%
financial results results
Schrödinger Reports Third Quarter 2021 Financial Results and Provides Company Update
Published: 2021-11-10 (Crawled : 00:00) - biospace.com/
SDGR | $24.04 -3.1% -3.2% 570K
|
Technology Services
|
| O: -4.94%
H: 0.0%
C: 0.0%
financial results results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.